From July 1, 2023 to August 17, 2023, the company has repurchased 132,328 shares, representing 1.65% for $0.42 million. With this, the company has completed the repurchase of 517,468 shares, representing 6.3% for $1.96 million under the buyback announced on August 16, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.02 USD | +0.67% | +7.47% | -5.03% |
Mar. 07 | Lumos Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 07 | Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.03% | 24.35M | |
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |
- Stock Market
- Equities
- LUMO Stock
- News Lumos Pharma, Inc.
- Tranche Update on Lumos Pharma, Inc.'s Equity Buyback Plan announced on August 16, 2022.